Fresenius Kabi secures contract for Pharmaceutical products - Pharmaceutical specialties based on piperacillin/tazobactam, flucloxacillin, linezolid, benzylpenicillin (sodium), vancomycin (hydrochloride), ceftazidime, meropenem (trihydrate), ciprofloxacin and ceftriaxone

Belgium, Sept. 1 -- Belgium based Fresenius Kabi has secured contract from Healthcare Public Procurement (HeCaPP) for Pharmaceutical products - Pharmaceutical specialties based on piperacillin/tazobactam, flucloxacillin, linezolid, benzylpenicillin (sodium), vancomycin (hydrochloride), ceftazidime, meropenem (trihydrate), ciprofloxacin and ceftriaxone . The value of the contract is worth 154491.2 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....